Remodeling Innovation: Applying Clinical Research and Real-World Experience with Cardiac Myosin Inhibition in HCM & Beyond

Join PeerView Live and Mended Hearts for a transformative exploration of therapy with cardiac myosin inhibitors (CMIs) in hypertrophic cardiomyopathy (HCM) and beyond! Through the lens of everyday patient care, leading experts will present the latest clinical research and real-world evidence on how CMIs are remodeling clinical practice in oHCM, nHCM, and HFpEF. The experts will also share essential skills for identifying suitable candidates for CMI therapy and developing personalized management plans using the principles of shared decision-making.

This CME/MOC/AAPA activity is provided by PVI, PeerView Institute for Medical Education.